Indication

Systemic Myasthenia Gravis

1 clinical trial

1 product

Clinical trial

A Study of RC18, a Recombinant Human B Lymphocyte Stimulator Receptor:Immunoglobulin G( IgG ) Fc Fusion Protein for Injection for the Treatment of Subjects With Systemic Myasthenia Gravis

Status: Completed, Estimated PCD: 2022-01-14

Product